Baxter International Inc.
- Jurisdiction
United States - LEI
J5OIVXX3P24RJRW5CK77 - ISIN
US0718131099 (BAX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. Read full profile
Fundamentals
- Net revenue
€9.29B - Gross margin
36.6% - EBIT
-€25.59M - EBIT margin
-0.3% - Net income
-€132.21M - Net margin
-1.4%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
| N/A | N/A |
Stock price
Dividends
- Last dividend amount
-
$0.17 - Ex date
-
- Payment date
-
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | September 12, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | June 9, 2025 | $1.00K–$15.00K |
| Debbie Wasserman Schultz | November 20, 2024 | $1.00K–$15.00K |
| Earl Blumenauer | August 6, 2024 | $15.00K–$50.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Ray Dalio |
|
|
|
Sell |
| John D. Spears |
|
|
|
Sell |
Earnings Calls
Latest earnings call: July 27, 2023 (Q2 2023)